June 3 (Reuters) - Immutep Ltd (IMM) :
- ENTERED INTO A CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT WITH MERCK & CO., INC
- DEAL TO EVALUATE EFTILAGIMOD ALFA IN COMBINATION WITH KEYTRUDA® & CHEMOTHERAPY FOR TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER
(([email protected];))
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $344.9M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.3¢ | $94.02K | 400.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 61318 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 294590 | 25 |
View Market Depth
| Last trade - 11.34am 11/09/2025 (20 minute delay) ? |
| IMM (ASX) Chart |